$0.70
Syndopa CR 125mg combines levodopa and carbidopa in a controlled-release formulation used for Parkinson’s disease management.
Syndopa CR 125mg combines Levodopa and Carbidopa in a controlled-release presentation. Levodopa is converted to dopamine in the brain, while carbidopa helps limit peripheral conversion of levodopa. Together, the ingredients form an established approach to Parkinson’s disease treatment.
$0.70
Syndopa CR 125mg combines levodopa and carbidopa in a controlled-release formulation used for Parkinson’s disease management.
Syndopa CR 125mg combines Levodopa and Carbidopa in a controlled-release presentation. Levodopa is converted to dopamine in the brain, while carbidopa helps limit peripheral conversion of levodopa. Together, the ingredients form an established approach to Parkinson’s disease treatment.
There are no reviews yet.
$0.70
Syndopa CR 125mg combines levodopa and carbidopa in a controlled-release formulation used for Parkinson’s disease management.
Syndopa CR 125mg combines Levodopa and Carbidopa in a controlled-release presentation. Levodopa is converted to dopamine in the brain, while carbidopa helps limit peripheral conversion of levodopa. Together, the ingredients form an established approach to Parkinson’s disease treatment.
There are no reviews yet.
Reviews
There are no reviews yet.